Legend Biotech Corporation
LEGN
$19.91
-$0.58-2.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.27B | 1.14B | 1.03B | 915.03M | 802.64M |
| Total Other Revenue | -93.00K | -90.00K | 0.00 | -5.92M | -5.66M |
| Total Revenue | 1.27B | 1.14B | 1.03B | 909.01M | 796.89M |
| Cost of Revenue | 552.07M | 512.67M | 408.07M | 358.55M | 298.71M |
| Gross Profit | 719.24M | 626.24M | 620.74M | 550.46M | 498.18M |
| SG&A Expenses | 375.02M | 359.32M | 341.72M | 323.69M | 315.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.20M | 4.20M | 2.00M | 1.00M | 1.00M |
| Total Operating Expenses | 1.33B | 1.27B | 1.17B | 1.10B | 1.02B |
| Operating Income | -56.15M | -135.75M | -137.65M | -191.96M | -218.87M |
| Income Before Tax | -56.27M | -236.57M | -282.67M | -222.53M | -304.34M |
| Income Tax Expenses | 35.33M | 13.63M | 14.23M | 17.25M | 21.07M |
| Earnings from Continuing Operations | -91.60 | -250.20 | -296.90 | -239.78 | -325.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -91.60M | -250.20M | -296.90M | -239.78M | -325.41M |
| EBIT | -56.15M | -135.75M | -137.65M | -191.96M | -218.87M |
| EBITDA | -45.15M | -126.45M | -128.45M | -182.70M | -210.39M |
| EPS Basic | -1.00 | -2.71 | -3.23 | -2.60 | -3.54 |
| Normalized Basic EPS | -0.20 | -0.80 | -0.96 | -0.74 | -1.02 |
| EPS Diluted | -1.05 | -2.76 | -3.26 | -2.61 | -3.54 |
| Normalized Diluted EPS | -0.20 | -0.80 | -0.96 | -0.75 | -1.03 |
| Average Basic Shares Outstanding | 741.47M | 738.62M | 737.27M | 735.86M | 734.51M |
| Average Diluted Shares Outstanding | 374.13M | 369.31M | 368.63M | 376.97M | 376.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |